Stay updated on p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.

Latest updates to the p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedAdded Gastric cancer as a listed condition/MeSH term in the study record. This broadens the documented scope of cancers associated with the trial.SummaryDifference0.0%

- Check13 days agoChange DetectedA new revision tag v3.4.2 was added and the previous government funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded an administrative notice about government funding and updated the page revision to v3.4.1; these changes do not affect the trial details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedNew items include a glossary toggle, a 'Last Update Submitted that Met QC Criteria' label, and the 'No FEAR Act Data' wording, alongside an updated site revision tag (v3.4.0). The corresponding older items—'Last Update Submitted that met QC Criteria' label, 'No FEAR Act data', and revision tag v3.3.4—were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a Locations section with Illinois and New Jersey entries and updated the revision to v3.3.3; removed the older Illinois and New Jersey Locations entries along with the HHS Vulnerability Disclosure (revision v3.3.2).SummaryDifference0.3%

Stay in the know with updates to p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the p53 Gene Therapy & Checkpoint Inhibitors in Solid Tumors Clinical Trial page.